Global Controlled Drug Delivery Market & Clinical Trial Outlook 2017-2022 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022" report to their offering.

Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022 report gives comprehensive clinical and non-clinical insight on the emergence and integration of controlled release technology in the drug delivery.

Report highlights the ongoing development of more than 300 controlled release drugs in clinical trials and helps to analyze the existing clinical mechanism of 133 commercially available controlled release drugs in the market.

The fundamentals and application of controlled release drug delivery encapsulated in the report helps to identify the various aspect of the growing controlled release drug delivery market.

Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022 report highlights:

- Evolution & Fundamentals of Controlled Drug Delivery

- Mode of Action & Approaches of Controlled Drug Delivery

- Global Controlled Release Drug Market Overview

- Insight on Global Controlled Release Drug Clinical Pipeline

- Clinical Insight on 303 Controlled Release Drug in Clinical Trials

- Clinical, Patent & Technology insight of 133 Marketed Controlled Release Drugs

- Controlled Release Drug Market Future Outlook

Key Topics Covered:

1. Drug Delivery: An Advancing Trajectory

2. Introduction to Controlled Drug Delivery

3. Evolution of Controlled Drug Delivery

4. Fundamentals of Controlled Drug Delivery

5. Mechanism of Controlled Drug Release

6. Cataloging of Controlled Drug Delivery

7. Approaches for Controlled Drug Delivery

8. Global Controlled Release Drug Clinical Pipeline Overview

9. Application of Controlled Drug Delivery

10. Drug Designing for Controlled Delivery

11. Market Inclinations

12. Global Controlled Drug Delivery Market Dynamics

13. Global Controlled Drug Delivery Market Future Outlook

14. Global Controlled Drug Delivery Clinical Trials by Company, Indication & Phase

15. Marketed Controlled Release Clinical Insight by Company, Indication & Phase

16. Competitive Landscape

  • Allergan
  • Amylin Pharmaceuticals
  • AstraZeneca
  • BioAlliance Pharma
  • Biogen
  • Collegium Pharmaceutical
  • Controlled Therapeutics (Ferring Pharmaceuticals)
  • Cosmo Pharmaceuticals
  • Egalet
  • Elan Corporation
  • Encore Therapeutics
  • Flamel Technologies
  • GlaxoSmithKline
  • Heron Therapeutics
  • iCeutica
  • Mithra Pharmaceuticals
  • Neurim Pharmaceuticals
  • Novartis
  • Orexigen Therapeutics
  • Otsuka Pharmaceutical
  • Pfizer
  • Purdue Pharma
  • Syntex Pharmaceuticals International
  • Takeda
  • Zealand Pharma

For more information about this report visit http://www.researchandmarkets.com/research/5tt87z/global_controlled

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery